Obesity And Health

The guideline reframes obesity as a chronic disease needing lifelong care, recommending GLP-1 therapies with behavioural support rather than relying on medication alone

A new clinical trial shows that kalonji, long used in Indian kitchens, may help lower cholesterol and slow fat formation, offering a natural metabolic boost alongside regular diet and lifestyle habits

Researchers warn that the findings reflect a growing global health crisis, as outdated BMI standards fail to capture hidden fat-linked risks contributing to chronic disease.

Children with "unhealthy obesity" were three times more likely born from high-risk pregnancies, linking early-life factors to later metabolic health risks

Ultra-processed foods, aggressive marketing and weak regulations are driving obesity among children. Unicef urges governments to act now to protect children's health and future potential

A global study reveals that millions go undiagnosed with diabetes. Researchers call for better education, early screening, and affordable treatment access

India's Rs 628-crore anti-obesity market sees heightened competition as Wegovy and Mounjaro post strong sales amid rising obesity and growing doctor awareness

Eli Lilly's Mounjaro has seen explosive growth since its March launch in India, with sales soaring to Rs 50 crore in three months

Wegovy is India's first weekly injectable approved for both long-term weight loss and reducing heart risks in obese and overweight adults

Belly fat growth patterns in childhood are tied to insulin resistance, high blood pressure, and early heart disease risk by age 10, finds a decade-long Danish study presented at ECO 2025

We Indians have had a different perspective around obesity

The number of Indian obese adults increased from 5.76 million in 1991 to 46.78 million in 2021; it is poised to reach 173.73 million by 2050

According to Unicommerce, order volumes for healthy food staples and snacks surged by 60 per cent year-on-year

The Medicines and Healthcare products Regulatory Agency (MHRA) began a review of safety data for the class of drugs, known as GLP-1 receptor agonists, more than a year ago

Obesity can no longer be just defined by body mass index (BMI) and rather should be about how body fat is distributed throughout one's body, researchers said while launching a new framework for diagnosing and managing obesity. Published in the journal Nature Medicine, the framework looks specifically at fat accumulated in the abdomen, measured as 'waist-to-height ratio' -- an increased value of which is related to a higher risk of developing cardiometabolic complications, according to the researchers. An "important novelty" of the framework is including a waist-to-height ratio higher than 0.5, along with a BMI of 25-30, for diagnosing obesity, the authors, representing the European Association for the Study of Obesity (EASO), said. "The choice of introducing waist-to-height ratio, instead of waist circumference, in the diagnostic process is due to its superiority as a cardiometabolic disease risk marker," they wrote. Accumulation of abdominal fat is a more reliable predictor of hea

The sales of Novo Nordisk's Rybelsus tablet, used for diabetes treatment and weight reduction, more than doubled to Rs 363 crore this year from Rs 147 crore last year

The company, helmed by Kiran Mazumdar Shaw, is leading the charge among Indian drugmakers - the world's largest supplier of generic medicines - as they race to grab a slice of the obesity drugs market

New obesity drugs such as Novo Nordisk A/S's Wegovy and Eli Lilly & Co.'s Zepbound could be an $80 billion market by 2030

About 12.5 million children aged between five and 19 in India were overweight in 2022, according to a global analysis published in The Lancet journal Of the 12.5, 7.3 million were boys and 5.2 million girls. The total number of children, adolescents and adults worldwide living with obesity has surpassed one billion. These trends, together with the declining prevalence of people underweight since 1990, make obesity the most common form of malnutrition in most countries, the researchers said. Obesity and underweight are both forms of malnutrition and are detrimental to people's health in many ways. The latest study provides a highly detailed picture of global trends in both forms of malnutrition over the last 33 years. The analysis by the NCD Risk Factor Collaboration (NCD-RisC) -- a global network of scientists -- and the World Health Organization (WHO) estimates that the rate of obesity among the world's children and adolescents in 2022 was four times the rate in 1990. It is very

About 12.5 million children aged between five and 19 in India were overweight in 2022, according to a global analysis published in The Lancet journal Of the 12.5, 7.3 million were boys and 5.2 million girls. The total number of children, adolescents and adults worldwide living with obesity has surpassed one billion. These trends, together with the declining prevalence of people who are underweight since 1990, make obesity the most common form of malnutrition in most countries, the researchers said. Obesity and underweight are both forms of malnutrition and are detrimental to people's health in many ways. The latest study provides a highly detailed picture of global trends in both forms of malnutrition over the last 33 years. The analysis by the NCD Risk Factor Collaboration (NCD-RisC) -- a global network of scientists -- and the World Health Organization (WHO) estimates that among the world's children and adolescents, the rate of obesity in 2022 was four times the rate in 1990. It